Bristol Myers to Acquire Karuna, a Neuroscience Drugmaker, for $14 Billion. Bristol Myers Squibb Company, Karuna Therapeutics Inc, Drugs (Pharmaceuticals), Mergers, Acquisitions and Divestitures, Mental Health and Disorders, Food and Drug Administration